Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Top Cited Papers
Open Access
- 19 December 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 35 (2) , 687-700
- https://doi.org/10.1093/nar/gkl1071
Abstract
A series of antisense oligonucleotides (ASOs) containing either 2′- O -methoxyethylribose (MOE) or locked nucleic acid (LNA) modifications were designed to investigate whether LNA antisense oligonucleotides (ASOs) have the potential to improve upon MOE based ASO therapeutics. Some, but not all, LNA containing oligonucleotides increased potency for reducing target mRNA in mouse liver up to 5-fold relative to the corresponding MOE containing ASOs. However, they also showed profound hepatotoxicity as measured by serum transaminases, organ weights and body weights. This toxicity was evident for multiple sequences targeting three different biological targets, as well as in mismatch control sequences having no known mRNA targets. Histopathological evaluation of tissues from LNA treated animals confirmed the hepatocellular involvement. Toxicity was observed as early as 4 days after a single administration. In contrast, the corresponding MOE ASOs showed no evidence for toxicity while maintaining the ability to reduce target mRNA. These studies suggest that while LNA ASOs have the potential to improve potency, they impose a significant risk of hepatotoxicity.Keywords
This publication has 51 references indexed in Scilit:
- Direct Comparison ofIn VivoAntisense Activity of ENA Oligonucleotides Targeting PTP1B mRNA with That of 2'-O-(2-Methoxy)ethyl-Modified OligonucleotidesOligonucleotides, 2006
- Double-stranded RNA-dependent Protein Kinase Phosphorylation of the α-Subunit of Eukaryotic Translation Initiation Factor 2 Mediates ApoptosisJournal of Biological Chemistry, 2006
- On the in vitro and in vivo Properties of Four Locked Nucleic Acid Nucleotides Incorporated into an Anti‐H‐Ras Antisense OligonucleotideChemBioChem, 2005
- A Functionally Improved Locked Nucleic Acid Antisense Oligonucleotide Inhibits Bcl-2 and Bcl-xL Expression and Facilitates Tumor Cell ApoptosisOligonucleotides, 2004
- A Functionally Improved Locked Nucleic Acid Antisense Oligonucleotide Inhibits Bcl-2 and Bcl-xL Expression and Facilitates Tumor Cell ApoptosisOligonucleotides, 2004
- Determination of the Role of the Human RNase H1 in the Pharmacology of DNA-like Antisense DrugsJournal of Biological Chemistry, 2004
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- Detection of the M30 Neoepitope as a New Tool to Quantify Liver Apoptosis Timing and Patterns of Positivity on Frozen and Paraffin-Embedded SectionsAmerican Journal of Clinical Pathology, 2004
- Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS1Published by Elsevier ,2002
- Second Generation Antisense Oligonucleotides—Inhibition of PKC-α andc-rafKinase Expression by Chimeric Oligonucleotides Incorporating 6″-Substituted Carbocyclic Nucleosides and 2″-O-Ethylene Glycol Substituted RibonucleosidesNucleosides and Nucleotides, 1997